share_log

Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Jayne David R.W.

Jul 11, 2022 06:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more